Search Results - "Latyszenok, V."

Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model by Sunyach, C., Michaud, M., Arnoux, T., Bernard-Marissal, N., Aebischer, J., Latyszenok, V., Gouarné, C., Raoul, C., Pruss, R.M., Bordet, T., Pettmann, B.

“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. The pathology is mimicked to a striking degree in transgenic mice carrying familial…”
Get full text

PB0784 Endothelial P2X7 Promotes Venous Thromboembolism by Ollivier, E., Gourdou-Latyszenok, V., Couturaud, F., Lemarie, C.

Get full text

OC 19.2 HDAC6 Regulates Endothelial Dysfunction in Thromboembolic Venous Disease by Pilard, M., Gourdou-Latyszenok, V., Robin, S., Couturaud, F., Lemarie, C.

Get full text

Endothelial P2X7 promotes venous thromboembolism by Ollivier, E., Gourdou-Latyszenok, V., Couturaud, F., Lemarie, C.

Get full text

TLR3 promotes venous thrombosis through neutrophil recruitment by Najem, M., Rys, R., Gourdou-Latyszenok, V., Couturaud, F., Blostein, M., Lemarie, C.

Get full text

Étude des propriétés prothrombotiques des polynucléaires neutrophiles dans les néoplasies myéloprolifératives by Guy, A., Deloison, L., Gourdou-Latyszenok, V., Favre, S., Colomer, S., James, C.

“…La thrombose est la complication la plus fréquente des néoplasies myéloprolifératives (NMP) BCR-ABL négatives mais sa physiopathologie reste encore floue…”
Get full text

TRO40303, a mitochondrial‐targeted cytoprotective compound, provides protection in hepatitis models by Schaller, Sophie, Michaud, Magali, Latyszenok, Virginie, Robert, Fabrice, Hocine, Mélanie, Arnoux, Thomas, Gabriac, Mélanie, Codoul, Hélène, Bourhane, Ahmed, Bellefois, Isabel Clémançon, Afxantidis, Jean, Pruss, Rebecca M.

“…TRO40303 is cytoprotective compound that was shown to reduce infarct size in preclinical models of myocardial infarction. It targets mitochondria, delays…”
Get full text